Tag: manufacturing defects

Investigating Tube Leakage During Transfer: Ensuring Inspection Readiness Tube leakage during transfer poses a significant risk in pharmaceutical manufacturing, particularly for aseptic products such as ointments and creams. This issue…

Addressing Phase Separation during Homogenization: A Comprehensive Investigation Guide Phase separation during homogenization is a significant concern within the pharmaceutical manufacturing sector, particularly for ointments and creams. When this phenomenon…

Investigating Phase Separation in Ointments During Homogenization: A Guide for Pharmaceutical Professionals Phase separation during the homogenization of ointments is a significant concern for pharmaceutical manufacturers, leading to potential product…

Understanding and Investigating Air Entrapment Defects During Homogenization In the pharmaceutical manufacturing process, achieving the right consistency and stability of ointments and creams is critical. However, frequent reports of air…

Investigation of Color Change Complaints During Homogenization: Ensuring Inspection Readiness In the world of pharmaceutical manufacturing, quality assurance is paramount. A common challenge faced by manufacturing professionals is the complaint…

Investigating Tube Leakage in Stability Studies: A Formulation and Process Perspective Tube leakage during stability studies presents a challenge in pharmaceutical manufacturing and quality control, particularly for ointments and creams.…

Investigation into Tube Leakage Following Bulk Hold: Formulation Versus Process Tube leakage after bulk hold is a significant manufacturing defect that can jeopardize product integrity and compliance with regulatory standards.…

Addressing Viscosity Drift Observed During Stability Studies: A Structured Investigation Approach Viscosity drift during stability studies poses significant challenges to pharmaceutical manufacturers, particularly for ointments and creams. This deviation can…

Assessing pH Drift Following Packaging Change: Essential Steps for Defect Investigation In pharmaceutical manufacturing, changes to packaging can inadvertently introduce significant quality risks, exemplified by instances of pH drift. Such…

Investigating Microbial Contamination Post Bulk Hold for Inspection Readiness In the pharmaceutical manufacturing realm, the risk of microbial contamination after bulk hold poses a significant challenge, particularly when it comes…

Understanding and Investigating Air Entrapment Defects Post Bulk Hold in Pharmaceutical Manufacturing The occurrence of air entrapment defects after bulk hold processes represents a significant challenge in pharmaceutical manufacturing, particularly…

Addressing Microbial Contamination in Bulk Holds: CAPA Insights Microbial contamination following a bulk hold presents a significant challenge in pharmaceutical manufacturing, particularly for ointment and cream formulations. This issue can…